Merit Medical Systems | MMSI - Loan Capital


Merit Medical Systems reported $734.04M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
3M USD 10.91B 26M Mar/2026
Abbott USD 9.9B 1.7B Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
AtriCure USD 61.86M 0 Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 11.01B 19M Dec/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 600M 1.7M Mar/2026
Globus Medical USD 436K 9K Dec/2025
Haemonetics USD 919.99M 406K Dec/2025
ICU Medical USD 1.27B 48.01M Dec/2025
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Olympus JPY 159.64B 74.23B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
STAAR Surgical USD 42K 42K Dec/2023
Stryker USD 14.86B 14M Dec/2025
Surmodics USD 29.67M 116K Jun/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Terumo JPY 99.9B 12M Dec/2025
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025